GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PixarBio Corp (GREY:PXRB) » Definitions » FCF Margin %

PixarBio (PixarBio) FCF Margin % : -373.33% (As of Sep. 2016)


View and export this data going back to 2016. Start your Free Trial

What is PixarBio FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. PixarBio's Free Cash Flow for the three months ended in Sep. 2016 was $-0.06 Mil. PixarBio's Revenue for the three months ended in Sep. 2016 was $0.02 Mil. Therefore, PixarBio's FCF Margin % for the quarter that ended in Sep. 2016 was -373.33%.

As of today, PixarBio's current FCF Yield % is 0.00%.

The historical rank and industry rank for PixarBio's FCF Margin % or its related term are showing as below:

PXRB' s FCF Margin % Range Over the Past 10 Years
Min: -181.71   Med: 0   Max: 0
Current: -181.71


PXRB's FCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -144.01 vs PXRB: -181.71


PixarBio FCF Margin % Historical Data

The historical data trend for PixarBio's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PixarBio FCF Margin % Chart

PixarBio Annual Data
Trend Dec14 Dec15
FCF Margin %
-57.45 -111.00

PixarBio Quarterly Data
Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only -104.76 -80.00 -190.91 -155.00 -373.33

Competitive Comparison of PixarBio's FCF Margin %

For the Biotechnology subindustry, PixarBio's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PixarBio's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PixarBio's FCF Margin % distribution charts can be found below:

* The bar in red indicates where PixarBio's FCF Margin % falls into.



PixarBio FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

PixarBio's FCF Margin for the fiscal year that ended in Dec. 2015 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2015 )/Revenue (A: Dec. 2015 )
=-0.111/0.1
=-111.00 %

PixarBio's FCF Margin for the quarter that ended in Sep. 2016 is calculated as

FCF Margin=Free Cash Flow (Q: Sep. 2016 )/Revenue (Q: Sep. 2016 )
=-0.056/0.015
=-373.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PixarBio FCF Margin % Related Terms

Thank you for viewing the detailed overview of PixarBio's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


PixarBio (PixarBio) Business Description

Traded in Other Exchanges
N/A
Address
200 Boston Avenue, Suite 1875, Medford, MA, USA, 02155
PixarBio Corp is a specialty pharmaceutical company focused on preclinical and clinical commercial development of therapeutic drug delivery systems for post-operative pain. The company's lead clinical candidate, NeuroRelease is a non-opioid / non-opiate preclinical stage product intended for the treatment of surgical pain, with planned future indications for chronic pain. NeuroRelease blocks nociceptive and neuropathic pain signals arising from temperature and pressure stimuli without affecting motor function, which is intended to allow for effective treatment without delaying post-surgical physical therapy.

PixarBio (PixarBio) Headlines